Paulson & Co. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2017$2,404,000
+311.6%
27,500
+75.3%
0.03%
+312.5%
Q1 2017$584,000
+21.2%
15,6900.0%0.01%
+33.3%
Q4 2016$482,000
-91.5%
15,690
-81.4%
0.01%
-90.2%
Q3 2016$5,666,000
+30.5%
84,500
-42.0%
0.06%
+38.6%
Q2 2016$4,343,000
+110.3%
145,800
+107.4%
0.04%
+193.3%
Q1 2016$2,065,000
-42.7%
70,300
+52.8%
0.02%
-31.8%
Q4 2015$3,606,00046,0000.02%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders